Á¦³×¸¯ ÀǾàǰ ½ÃÀåÁ¶»çº¸°í¼­

Global InformationÀÌ Á¦°øÇϰí ÀÖ´Â Á¦³×¸¯ ÀǾàǰ(Generics), ¹ÙÀÌ¿À½Ã¹Ð·¯(Biosimilar), ¹ÙÀÌ¿Àº£ÅÍ(Biobetter) °ü·Ã º¸°í¼­¿¡¼­´Â ÇöÀç¿Í ÇâÈÄÀÇ Á¦³×¸¯ ÀǾàǰ ½ÃÀå ȯ°æ ºÐ¼® Á¤º¸¸¦ ÀüÇØµå¸®°í ÀÖ½À´Ï´Ù. ¶Ç ƯÇã ¸¸·á ´ëÃ¥°ú ÀǾàǰ ¼ö¸íÁֱ⠰ü¸®, ½ÃÀå ÁøÃâ ±âȸ, ½ÇÀû »óÈ£ºñ±³ µîÀÇ Á¤º¸µµ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 122°Ç)
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå(2020-2027³â)
Global Biosimilars Market - 2020-2027
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 3,750 £Ü 4,263,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : Á¦Ç°, ÀÀ¿ë, ±ÔÁ¦
Global Biosimilars Market - Products, Applications and Regulations
¹ßÇà 2021³â 01¿ù
°¡°Ý US $ 4,050 £Ü 4,604,000
¼¼°èÀÇ ÇÊ±×¶ó½ºÆÀ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ±âȸ¿Í Àü·«(-2030³â) : COVID-19¿¡ ÀÇÇÑ ¿µÇâ°ú ¼ºÀå
Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ È£¸£¸ó ½ÃÀå(2020-2030³â) : COVID-19¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Biosimilar Hormones Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀÎÅÍ·ùŲ ½ÃÀå(2020-2030³â) : Covid-19¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Biosimilar Interleukins Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¸®Åö½Ã¸¿ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå(2020-2030³â) : COVID-19¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Rituximab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ÇÊ±×¶ó½ºÆÀ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ºÐ¼®(2020-2030³â) : ½ÅÁ¾ Äڷγª ¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)¿¡ µû¸¥ ¼ºÀå ¹× º¯È­
Filgrastim Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯(¾Æ´Þ¸®¹«¸¿, ÀÎÇø¯½Ã¸¿, ¿¡Å¸³Ê¼ÁÆ®) ½ÃÀå(2020-2030³â) : Covid-19¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ´ÜÀÏŬ·ÐÇ×ü ½ÃÀå(2020-2030³â) : ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19)¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Biosimilar Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
º£¹Ù½ÃÁÖ¸¿ ¹ÙÀÌ¿À½Ã¹Ð·¯ : ½ÃÀå ±âȸ, ¸ÅÃâ, °¡°Ý µ¿Çâ, ÀÓ»ó½ÃÇè µ¿Ç⠺м®(2025³â)
Bevacizumab Biosimilar Market Opportunity , Sales, Price & Clinical Trials Insight 2025
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,000 £Ü 2,273,000
Å׸®ÆÄ¶óŸÀ̵å(Teriparatide) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Teriparatide- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 1,500 £Ü 1,705,000
Æä±×ÇÊ±×¶ó½ºÆÀ(Pegfilgrastim) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Pegfilgrastim- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,000 £Ü 2,273,000
Æú¸®Æ®·ÎÇÉ ¾ËÆÄ(Follitropin alfa) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Follitropin alfa- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 1,500 £Ü 1,705,000
¿¡Å¸³Ê¼ÁÆ®(Etanercept) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Etanercept- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 2,000 £Ü 2,273,000
¿¡Æ÷Å×ÀÎ ¾ËÆÄ(Epoetin alfa) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Epoetin alfa- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 1,500 £Ü 1,705,000
´Ùº£Æ÷¿¡Æ¾ ¾ËÆÄ(Darbepoetin Alfa) : ¹ÙÀÌ¿À½Ã¹Ð·¯ ÀλçÀÌÆ®(2020³â)
Darbepoetin alfa- Biosimilar Insight, 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 1,500 £Ü 1,705,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ÆÄÆ®³Ê¸µ Á¶°Ç°ú ÇÕÀÇ(2010-2020³â)
Global Biosimilars Partnering Terms and Agreements 2010 to 2020
¹ßÇà 2020³â 12¿ù
°¡°Ý US $ 3,495 £Ü 3,973,000
¼¼°èÀÇ Æ®¶ó½ºÅõÁÖ¸¿ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå(2020-2030³â) : COVID-19¿¡ ÀÇÇÑ ¼ºÀå°ú º¯È­
Trastuzumab Biosimilars Global Market Report 2020-30: Covid 19 Growth and Change
¹ßÇà 2020³â 11¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
¼¼°èÀÇ ¾Æ´Þ¸®¹«¸¿ ½ÃÀå(2020-2027³â)
Global Adalimumab Market - 2020-2027
¹ßÇà 2020³â 11¿ù
°¡°Ý US $ 3,750 £Ü 4,263,000
¼¼°èÀÇ ¾Æ´Þ¸®¹«¸¿(Adalimumab) ½ÃÀå : ¾÷°è µ¿Çâ°ú ¿¹Ãø(-2027³â)
Global Adalimumab Market - Industry Trends and Forecast to 2027
¹ßÇà 2020³â 11¿ù
°¡°Ý US $ 4,800 £Ü 5,457,000
Çã¼Áƾ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : ±Ô¸ð, Á¡À¯À², Àü¸Á, ±âȸ ºÐ¼®(2020-2027³â)
Herceptin Biosimilar Market, by Indication, by Distribution Channel and by Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
¹ßÇà 2020³â 10¿ù
°¡°Ý US $ 4,500 £Ü 5,116,000
¼¼°èÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå : »õ·Î¿î Ä¡·á ºÐ¾ß·ÎÀÇ ¾×¼¼½º¿¡ ÀÇÇÑ ´ëÆøÀûÀÎ ½ÃÀå ¼ºÀå ÃËÁø(2020-2026³â)
Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020-2026
¹ßÇà 2020³â 10¿ù
°¡°Ý US $ 4,950 £Ü 5,627,000
¼¼°èÀÇ °æ±¸ »ý¹°Á¦Á¦ ¹× ¹ÙÀÌ¿À½Ã¹Ð·¯ ½ÃÀå ±âȸ¿Í Àü·«(-2030³â)
Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030
¹ßÇà 2020³â 10¿ù
°¡°Ý US $ 4,000 £Ü 4,547,000
Á¦³×¸¯ ÀǾàǰ : ¼¼°è ÁÖ¿ä 8°³±¹(G8) ¾÷°è °¡À̵å(2015-2024³â)
Generics Global Group of Eight (G8) Industry Guide 2015-2024
¹ßÇà 2020³â 09¿ù
°¡°Ý US $ 1,495 £Ü 1,699,000
Á¦³×¸¯ ÀǾàǰ : ¼¼°è ¾÷°è ¿¬°¨(2015-2024³â)
Generics Global Industry Almanac 2015-2024
¹ßÇà 2020³â 09¿ù
°¡°Ý US $ 2,995 £Ü 3,405,000
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 koreainfo@gii.co.jp
¨Ï Copyright Global Information, Inc. All rights reserved.